Ultroid® Technologies, Inc. Retains Armor Capital Management for Advisory Role

TAMPA, Fla.--()--Ultroid® Technologies, Inc. announces today it has retained Armor Capital Management, Inc. Armor Capital will provide M&A advisory services on all aspects of acquisitions, sales/divestitures, private equity transactions and finance raising, as Ultroid® Technologies, Inc. expands its operations simultaneously throughout the United States and Global markets. Its flagship product is the Ultroid® Hemorrhoid Management System, a non-invasive, painless, and low cost treatment alternative. This novel treatment for Hemorrhoidal Disease (HD) is applicable, and FDA approved, for all four grades of internal hemorrhoids. The Ultroid® System has been effective in over 150,000 procedures to date with no reported complications. The system provides a safe and effective alternative to surgery for the millions of people suffering from hemorrhoid disease and the painful symptoms of (HD). Physicians perform the non-invasive, 15 minute procedures in their office, without anesthesia, and experience exceptional patient outcomes. This is a permanent alternative to ineffective topical creams or the painful downtime and recovery of hemorrhoid surgeries. The Ultroid® System is a quick, easy, painless, and proven solution that requires no preparation, with most people returning to their usual daily activities immediately after the treatment. No negative side effects have been reported.

About Ultroid® Technologies, Inc.:

Ultroid® Technologies, Inc. is a leader in non-invasive, low cost, micro current technologies in the United States and around the world. The Ultroid ® System replaces over-the-counter creams and painful surgeries by providing a quick, painless, and permanent solution to (HD)without interrupting daily activities.

The Company’s website is http://www.Ultroid.com. The brand names referenced in this press release are trademarks of Ultroid® Technologies, Inc. its affiliated companies, customers, or other third parties. The company markets and manufactures the Ultroid® Hemorrhoid Management System.

About Armor Capital Management

Armor Capital Management is a private equity firm that invests in exceptional companies that meet their strict financial, and strategic parameters. Armor Capital makes long term investments with the goal of increasing financial performance, thus creating value for the entire ecosystem of customers, employees, stockholders, and communities.

Safe Harbor Statements

This report includes “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, reflecting management’s current expectations regarding future results of operations, economic performance, financial condition and achievements of the Company. The forward-looking statements are based on the assumption that operating performance will continue to exponentially grow in line with recent trends and consistent with distribution expansion. Management believes these assumptions to be reasonable but there is no assurance that they will prove to be accurate. Forward-looking statements, specifically those concerning future performance are subject to certain risks and uncertainties, and actual results may differ materially. These risks and uncertainties are detailed from time to time in the Company’s filings. The Company undertakes no obligation to publicly update or revise any forward-looking statements.


Ultroid® Technologies, Inc.
Michael Knox, 727-898-0717
Chief Executive Officer
Armor Capital Management Inc.
Mat Khokhar, 407-924-1548